The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein
Open accessAbstract
The immune response against hepatitis C virus (HCV) is rarely effective at clearing the virus, resulting in ∼170 million chronic HCV infections worldwide. Here we report that ligation of an HCV receptor (CD81) inhibits natural killer (NK) cells. Cross-linking of CD81 by the major envelope protein of HCV (HCV-E2) or anti-CD81 antibodies blocks NK cell activation, cytokine production, cytotoxic granule release, and proliferation. This inhibitory effect was observed using both activated and resting NK cells. Conversely, on NK-like T cell clones, including those expressing NK cell inhibitory receptors, CD81 ligation delivered a costimulatory signal. Engagement of CD81 on NK cells blocks tyrosine phosphorylation through a mechanism which is distinct from the negative signaling pathways associated with NK cell inhibitory receptors for major histocompatibility complex class I. These results implicate HCV-E2–mediated inhibition of NK cells as an efficient HCV evasion strategy targeting the early antiviral activities of NK cells and allowing the virus to establish itself as a chronic infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Biology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113
Binding of Hepatitis C Virus to CD81
Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., et al. (1998) · Science · doi:10.1126/science.282.5390.938 · Cited by 2,066
Self-citationLanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Lanier, L. L., Le, A. M., Civin, C. I., Loken, M. R., & Phillips, J. H. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.12.4480 · Cited by 1,129
The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies
Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J. C., Strazzera, A., Chien, D. Y., Munoz, S. J., Balestrieri, A., et al. (2000) · Science · doi:10.1126/science.288.5464.339 · Cited by 884
Inhibition of the Interferon- Inducible Protein Kinase PKR by HCV E2 Protein
Taylor, D. R., Shi, S. T., Romano, P. R., Barber, G. N., & Lai, M. M. C. (1999) · Science · doi:10.1126/science.285.5424.107 · Cited by 733
Recruitment of Tyrosine Phosphatase HCP by the Killer Cell Inhibitory Receptor
Burshtyn, D. N., Scharenberg, A. M., Wagtmann, N., Rajagopalan, S., Berrada, K., Yi, T., Kinet, J.-P., & Long, E. O. (1996) · Immunity · doi:10.1016/s1074-7613(00)80300-3 · Cited by 613
CD81 (TAPA-1): A MOLECULE INVOLVED IN SIGNAL TRANSDUCTION AND CELL ADHESION IN THE IMMUNE SYSTEM
Levy, S., Todd, S. C., & Maecker, H. T. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.89 · Cited by 511
Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells
Lanier, L. L., Yu, G., & Phillips, J. H. (1989) · Nature · doi:10.1038/342803a0 · Cited by 432
Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence
Cerny, A., & Chisari, F. V. (1999) · Hepatology · doi:10.1002/hep.510300312 · Cited by 410
Phillips, J. H., Gumperz, J. E., Parham, P., & Lanier, L. L. (1995) · Science · doi:10.1126/science.7716542 · Cited by 305
PERUSSIA, B., Ramoni, C., Anegón, I., Cuturi, M. C., Faust, J. S., & Trinchieri, G. (1987) · PubMed · Cited by 181
Litwin, V, Gumperz, J., Parham, P., Phillips, J. H., & Lanier, L. L. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1321 · Cited by 173
Nuti, S., Rosa, D., Valiante, N. M., Saletti, G., Caratozzolo, M., Dellabona, P., Barnaba, V., & Abrignani, S. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199811)28:11<3448::aid-immu3448>3.0.co;2-5 · Cited by 161
Self-citationLife, activation and death of intrahepatic lymphocytes in chronic hepatitis C
Valiante, N., D'Andrea, A., Crotta, S., Lechner, F., Klenerman, P., Nuti, S., Wack, A., & Abrignani, S. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017417.x · Cited by 95
Self-citationEinspahr, K. J., Abraham, R. T., Binstadt, B. A., Uehara, Y., & Leibson, P. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6279 · Cited by 93
Fc Receptors on Natural Killer Cells
PERUSSIA, B. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-46859-9_6 · Cited by 79
Milella, M., Gismondi, A., Roncaioli, P., Bisogno, L., Palmieri, G., Frati, L., Cifone, M. G., & Santoni, A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.7.3148 · Cited by 66
A novel cytotoxic T lymphocyte activation assay
Takayama, H., Trenn, G., & Sitkovsky, M. V. (1987) · Journal of Immunological Methods · doi:10.1016/0022-1759(87)90502-3 · Cited by 59
FcγRIII activation is different in CD16+ cytotoxic T lymphocytes and natural killer cells
Uciechowski, P., Gessner, J. E., Schindler, R., & Schmidt, R. E. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220643 · Cited by 25
Cited by
Immunology of hepatitis B virus and hepatitis C virus infection
Rehermann, B., & Nascimbeni, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1573 · Cited by 1,627
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,179
Modulation of natural killer cell activity by viruses
Lisnić, V. J., Krmpotić, A., & Jonjić, S. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.05.011 · Cited by 1,003
IMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
Guidotti, L. G., & Chisari, F. V. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100230 · Cited by 811
Adaptive immune responses in acute and chronic hepatitis C virus infection
Bowen, D. G., & Walker, C. M. (2005) · Nature · doi:10.1038/nature04079 · Cited by 756
Metadata
- Authors
- Crotta, S., Stilla, A., Wack, A., D'Andrea, A., Nuti, S., D'Oro, U., Mosca, M., Filliponi, F., Brunetto, R. M., Bonino, F., Abrignani, S., & Valiante, N. M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2001-12-31
- Volume
- 195
- Issue
- 1
- Pages
- 35-42
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2118888785
- Cited by
- 471
- References
- 24
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.